Scott A. Boerner
- Hepatology top 5%
- Oncology top 5%
- PARP inhibition in cancer therapy 8
- Cancer-related Molecular Pathways 3
- Immunology and Allergy top 5%
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 6
- Molecular Biology top 10%
- DNA Repair Mechanisms 6
- Cancer therapeutics and mechanisms 6
- PI3K/AKT/mTOR signaling in cancer 5
- Melanoma and MAPK Pathways 3
-
- Lung Cancer Treatments and Mutations 4
- Co-authors
- Patricia LoRussoJoseph P. EderGeorge F. Vande WoudeJ. Thomas ParsonsKaren H. MartinScott H. KaufmannJill K. SlackJames D. Winkler
- Journals
- Clinical Cancer Research (7 papers)Investigational New Drugs (4 papers)Journal of Clinical Oncology (4 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Scott A. Boerner
40 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 106
- Hepatology 278
- Oncology 852
- Immunology and Allergy 154
- Cancer Research 334
- Molecular Biology 1.2k
Countries citing papers authored by Scott A. Boerner
This map shows the geographic impact of Scott A. Boerner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott A. Boerner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott A. Boerner more than expected).
Fields of papers citing papers by Scott A. Boerner
This network shows the impact of papers produced by Scott A. Boerner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott A. Boerner. The network helps show where Scott A. Boerner may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Scott A. Boerner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 6 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 18 | |
| 4 | 2023 | 2 | |
| 5 | 2015 | 22 | |
| 6 | 2012 | 30 | |
| 7 | 2010 | 1 | |
| 8 | 2010 | 16 | |
| 9 | 2010 | 52 | |
| 10 | 2008 | 54 | |
| 11 | 2008 | 10 | |
| 12 | 2008 | 85 | |
| 13 | 2006 | 136 | |
| 14 | 2005 | 32 | |
| 15 | 2002 | 6 | |
| 16 | 2002 | 64 | |
| 17 | 2002 | 14 | |
| 18 | 2002 | 190 | |
| 19 | 2001 | 15 | |
| 20 | 1999 | 24 |
About Scott A. Boerner
Scott A. Boerner is a scholar working on Oncology, Structural Biology and Cancer Research, having authored 40 papers that have together received 2.2k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (8 papers), DNA Repair Mechanisms (6 papers), Cancer therapeutics and mechanisms (6 papers), Cancer Genomics and Diagnostics (6 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Lung Cancer Treatments and Mutations (4 papers), Melanoma and MAPK Pathways (3 papers) and Cancer-related Molecular Pathways (3 papers). The work is most often cited by research in Hepatology (278 citations), Oncology (852 citations) and Immunology and Allergy (154 citations). Scott A. Boerner has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Patricia LoRusso, Joseph P. Eder, George F. Vande Woude, J. Thomas Parsons, Karen H. Martin, Scott H. Kaufmann, Jill K. Slack, James D. Winkler, Ding Wang and Keith C. Bible. Their work appears in journals such as Clinical Cancer Research, Investigational New Drugs, Journal of Clinical Oncology, Journal of Immunotherapy and The Journal of Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.